Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab with TCS in moderate-to-severe atopic dermatitis
NCT01639040Phase 2Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Jul 2012
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of dupilumab in atopic dermatitis (AD), sponsored by Regeneron Pharmaceuticals. Started Jul 2012; status: completed.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01639040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01639040.